Your browser doesn't support javascript.
loading
Low vitamin D levels do not predict risk of autoimmune disease following alemtuzumab treatment for multiple sclerosis.
Arnett, Simon; Sanchez, Sofia Jimenez; Downing, Jennifer; Boggild, Mike; Sun, Jing; Broadley, Simon A.
Afiliação
  • Arnett S; Menzies Health Institute Queensland, Gold Coast Campus, Griffith University QLD 4222, Australia; Department of Neurology, Gold Coast University Hospital, Southport QLD 4215, Australia. Electronic address: simon.arnett@griffithuni.edu.au.
  • Sanchez SJ; Menzies Health Institute Queensland, Gold Coast Campus, Griffith University QLD 4222, Australia.
  • Downing J; Department of Neurology, Gold Coast University Hospital, Southport QLD 4215, Australia.
  • Boggild M; Department of Neurology, Townsville University Hospital, Douglas QLD 4814, Australia.
  • Sun J; Menzies Health Institute Queensland, Gold Coast Campus, Griffith University QLD 4222, Australia.
  • Broadley SA; Menzies Health Institute Queensland, Gold Coast Campus, Griffith University QLD 4222, Australia; Department of Neurology, Gold Coast University Hospital, Southport QLD 4215, Australia.
Mult Scler Relat Disord ; 59: 103511, 2022 Mar.
Article em En | MEDLINE | ID: mdl-35093841

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Idioma: En Ano de publicação: 2022 Tipo de documento: Article